Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYD Dengue Vaccine in Healthy Indian Adults
NCT01550289Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2012
- Primary completion
- Dec 2013
- Modality
- Live Attenuated Vaccines, Recombinant Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Cyd dengue virus serotype 1 live (attenuated) antigen in dengue fever, sponsored by Sanofi. Started Mar 2012; status: completed.
02
Drugs
Cyd dengue virus serotype 1 live (attenuated) antigen
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT01550289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01550289.